Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Down 75% From Its High, Is TMC The Metals Company Stock a Buy?

TMC stock is swimming in uncertainty.

Billions of potato-sized rocks, known as polymetallic nodules, are scattered across the bottom of the Pacific Ocean. These nodules contain critical metals like nickel, copper, cobalt, and manganese, which are difficult to source and mine on land. Currently, nobody has the legal right to commercialize these nodules. TMC The Metals Company is attempting to become the first to obtain this right.

If granted, TMC's stock could experience a significant increase in value. However, there is no certainty that TMC will ever mine these nodules at sea, at least in the near future. TMC has demonstrated that its machines can collect nodules from the seafloor and holds exploration rights over vast stretches of the Pacific seabed, containing enormous lodes of valuable metals.

Despite these positive aspects, TMC faces a major obstacle: it doesn't have permission to mine the nodules commercially. The International Seabed Authority (ISA), established by the United Nations Convention on the Law of the Sea, has not finalized regulations governing commercial deep-sea mining. Consequently, TMC has sought permission from the U.S. government, which has become more supportive of deep-sea mining as it seeks to reduce its reliance on foreign sources of land-mined minerals.

While the U.S. could permit TMC to mine nodules commercially under its own legal framework, doing so could lead to legal and diplomatic controversies if the ISA maintains its position that mining in international waters must be governed through its framework. This uncertainty makes TMC a high-risk investment, as it presents significant potential upside but also substantial risks of substantial losses.

TMC is best suited for investors with a high risk tolerance and a willingness to accept the unknown.

Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fool.com →

More in Finance & Markets

Lifeway: 3 Key Takeaways for Long-Term Investors

Health-driven shelf gains could matter as much as the production plant upgrade if demand from GLP-1 users holds, but margin recovery remains unproven.

  • Record net sales of $67.8 million reported in Q3 2026
  • Waukesha facility expansion to double bottling capacity by early 2027
  • Gross margins impacted by high milk prices, aiming for 25%+

More from Friday 13 November →